Translational pharmaceuticals in retinal disease
Please note that for mobiles we stream the presentation slides and audio of the speaker.
You must login to watch this lecture.
Kevin Gregory-Evans examines new approaches to treating common retinal diseases, explaining both research and testing. He encourages the development of new therapeutics in order to stop the most common cause of blindness.
This lecture was part of an event called "The Lang lecture: Professor Kevin Gregory-Evans supported by J.E.J White” at The Royal Society of Medicine in London.
Date of lecture: 10th October 2013
This video is available for iPad via Safari
Tips about RSM Videos
- This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
- This video is linked to a CPD credit. Both RSM members and non-members must login before watching the video to be able to claim a CPD credit.
- Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
- Click on the Chapters tab to view different parts of the video.